Gaurav Aggarwal, Chief Business Officer at Ocera Therapeutics, Inc. (OCRX), bought 7,500 shares at $3.62 ($27K) on 2015-05-06, disclosed to the SEC on 2015-05-06.
Open-market purchase of $27k OCRX by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| HPTX | BUY | 2012-08-02 | $50K | — | Filing → |